1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell TherapyInflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndromeRecruitingPhase 1 / Phase 22026-08-31NCT05905328